Your browser doesn't support javascript.
loading
All-in-One Spinal Cord Stimulation in Lymphoproliferative Diseases.
Sica, Antonello; Casale, Beniamino; Sagnelli, Caterina; Di Dato, Maria Teresa; Buonavolontà, Pietro; Salzano, Anna Maria; Sagnelli, Evangelista; Famiglietti, Vincenzo; Saracco, Elisabetta; Tammaro, Dario; Papa, Alfonso.
Afiliação
  • Sica A; Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Casale B; Department of Pain Therapy Monaldi Hospital-Azienda Ospedaliera di Rilievo Nazionale Ospedali dei Colli, Naples, Italy.
  • Sagnelli C; Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Di Dato MT; Department of Pain Therapy Monaldi Hospital-Azienda Ospedaliera di Rilievo Nazionale Ospedali dei Colli, Naples, Italy.
  • Buonavolontà P; Department of Pain Therapy Monaldi Hospital-Azienda Ospedaliera di Rilievo Nazionale Ospedali dei Colli, Naples, Italy.
  • Salzano AM; Department of Pain Therapy Monaldi Hospital-Azienda Ospedaliera di Rilievo Nazionale Ospedali dei Colli, Naples, Italy.
  • Sagnelli E; Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Famiglietti V; Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Saracco E; Department of Pain Therapy Monaldi Hospital-Azienda Ospedaliera di Rilievo Nazionale Ospedali dei Colli, Naples, Italy.
  • Tammaro D; Department of Pain Therapy Monaldi Hospital-Azienda Ospedaliera di Rilievo Nazionale Ospedali dei Colli, Naples, Italy.
  • Papa A; Department of Pain Therapy Monaldi Hospital-Azienda Ospedaliera di Rilievo Nazionale Ospedali dei Colli, Naples, Italy.
Front Neurol ; 11: 550554, 2020.
Article em En | MEDLINE | ID: mdl-33281699
ABSTRACT
Even patients with lymphoproliferative diseases may develop a persistent chronic pain not responsive to usual treatments due to changes in antibody production and to some treatments like radiotherapy, chemotherapy, and the administration of monoclonal antibodies, which further impair the immune defense and induce chronic inflammatory phenomena acting as a substrate for a persistent chronic pain. Five patients with indolent lymphoproliferative diseases were treated for severe pain nonresponsive to other pain reliever treatments with SCS applied with an All-in-One Shot (OS) procedure. For all patients, the estimated survival time was of 5 years or more. All patients showed a significant reduction of the intensity of pain the mean Numerical Rating Scale was 7.4 before treatment and 2.2 after. No patient developed adverse events. Supported by the data of this study, we believe that the habit to deprive patients with an indolent form of lymphoproliferative diseases of the possibility to reduce the intensity of chronic pain by SCS treatment is extremely reductive and frustrating.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article